Carmen studied Biology at the University of Alcalá (Spain). She then pursued a Master’s degree at University College London (UK) and completed a PhD in Biomedicine at the University of Barcelona (Spain) in 2017, under the supervision of Dr. George Thomas. During her PhD, she studied the role of a complex formed by two ribosomal proteins and the 5S ribosomal RNA in mediating p53 levels in response to c-Myc levels. In May 2018 she joined the Molecular and Cell Biology lab (MCB) at the Institutes of Biomedical Sciences of Fudan University, where she is now working on deciphering how TCA cycle-derived metabolites can affect both cancer development and the immune system by directly acting on epigenetic regulators.